View:
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
(RULE 13D-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13D-1(B), (C) AND (D) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13D-2(B)
(AMENDMENT NO. ____________)*
REGENERON PHARMACEUTICALS, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $0.001 per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
75886F 10 7
- --------------------------------------------------------------------------------
(CUSIP Number)
March 23, 2001
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[_] Rule 13d-1(b)
[X] Rule 13d-1(c)
[_] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act, but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 16
Exhibit Index on Page 11
CUSIP NO. 75886F 10 7 13G PAGE 2 --------- of ------- 16 PAGES
---
1 Names of Reporting Persons/I.R.S. Identification Nos. of Above
Persons (Entities Only)
Feldon Invest SA
- --------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (a) [ ]
(See Instructions) (b) [ ]
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Citizenship or Place of Organization
Panama
- --------------------------------------------------------------------------------
Number of 5 Sole Voting Power
N/A
------------------------------------------------------------------
Shares 6 Shared Voting Power
4,000,000
------------------------------------------------------------------
Beneficially 7 Sole Dispositive Power
N/A
------------------------------------------------------------------
Owned by 8 Shared Dispositive Power
Each
Reporting 4,000,000
Person With
- --------------------------------------------------------------------------------
9 Aggregate Amount Beneficially Owned by Each Reporting Person
4,000,000
- --------------------------------------------------------------------------------
10 Check if the Aggregate Amount in Row (9) Excludes Certain
Shares [ ] (See Instructions)
- --------------------------------------------------------------------------------
11 Percent of Class Represented by Amount in Row (9)
9.8%
- --------------------------------------------------------------------------------
12 Type of Reporting Person (See Instructions)
CO
- --------------------------------------------------------------------------------
CUSIP NO. 75886F 10 7 13G PAGE 3 --------- of ------- 16 PAGES
---
1 Names of Reporting Persons/I.R.S. Identification Nos. of Above
Persons (Entities Only)
Emfeld Ltd
- --------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (a) [ ]
(See Instructions) (b) [ ]
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Citizenship or Place of Organization
Cayman Islands
- --------------------------------------------------------------------------------
Number of 5 Sole Voting Power
N/A
------------------------------------------------------------------
Shares 6 Shared Voting Power
4,000,000
------------------------------------------------------------------
Beneficially 7 Sole Dispositive Power
N/A
------------------------------------------------------------------
Owned by 8 Shared Dispositive Power
Each
Reporting 4,000,000
Person With
- --------------------------------------------------------------------------------
9 Aggregate Amount Beneficially Owned by Each Reporting Person
4,000,000
- --------------------------------------------------------------------------------
10 Check if the Aggregate Amount in Row (9) Excludes Certain
Shares [ ] (See Instructions)
- --------------------------------------------------------------------------------
11 Percent of Class Represented by Amount in Row (9)
9.8%
- --------------------------------------------------------------------------------
12 Type of Reporting Person (See Instructions)
CO
- --------------------------------------------------------------------------------
CUSIP NO. 75886F 10 7 13G PAGE 4 --------- of ------- 16 PAGES
---
1 Names of Reporting Persons/I.R.S. Identification Nos. of Above
Persons (Entities Only)
Bertarelli & Cie
- --------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (a) [ ]
(See Instructions) (b) [ ]
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Citizenship or Place of Organization
Switzerland
- --------------------------------------------------------------------------------
Number of 5 Sole Voting Power
N/A
------------------------------------------------------------------
Shares 6 Shared Voting Power
4,000,000
------------------------------------------------------------------
Beneficially 7 Sole Dispositive Power
N/A
------------------------------------------------------------------
Owned by 8 Shared Dispositive Power
Each
Reporting 4,000,000
Person With
- --------------------------------------------------------------------------------
9 Aggregate Amount Beneficially Owned by Each Reporting Person
4,000,000
- --------------------------------------------------------------------------------
10 Check if the Aggregate Amount in Row (9) Excludes Certain
Shares [ ] (See Instructions)
- --------------------------------------------------------------------------------
11 Percent of Class Represented by Amount in Row (9)
9.8%
- --------------------------------------------------------------------------------
12 Type of Reporting Person (See Instructions)
OO
- --------------------------------------------------------------------------------
CUSIP NO. 75886F 10 7 13G PAGE 5 --------- of ------- 16 PAGES
---
1 Names of Reporting Persons/I.R.S. Identification Nos. of Above
Persons (Entities Only)
Ernesto Bertarelli
- --------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (a) [ ]
(See Instructions) (b) [ ]
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Citizenship or Place of Organization
Switzerland
- --------------------------------------------------------------------------------
Number of 5 Sole Voting Power
N/A
------------------------------------------------------------------
Shares 6 Shared Voting Power
4,000,000
------------------------------------------------------------------
Beneficially 7 Sole Dispositive Power
N/A
------------------------------------------------------------------
Owned by 8 Shared Dispositive Power
Each
Reporting 4,000,000
Person With
- --------------------------------------------------------------------------------
9 Aggregate Amount Beneficially Owned by Each Reporting Person
4,000,000
- --------------------------------------------------------------------------------
10 Check if the Aggregate Amount in Row (9) Excludes Certain
Shares [ ] (See Instructions)
- --------------------------------------------------------------------------------
11 Percent of Class Represented by Amount in Row (9)
9.8%
- --------------------------------------------------------------------------------
12 Type of Reporting Person (See Instructions)
IN
- --------------------------------------------------------------------------------
CUSIP NO. 75886F 10 7 13G PAGE 6 --------- of ------- 16 PAGES
---
ITEM 1(A). NAME OF ISSUER:
Regeneron Pharmaceuticals, Inc.
ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
777 Old Saw Mill River Road
Tarrytown, New York 10591-6707
ITEM 2(A). NAMES OF PERSONS FILING:
This statement is being filed jointly by:
(i) Feldon Invest SA, a Panamanian stock company, the holder of
an aggregate of 4,000,000 shares of the issuer's common
stock, par value $0.001;
(ii) Emfeld Ltd, a Cayman Islands stock company, which is the
holder of all of the issued and outstanding capital stock of
Feldon Invest SA;
(iii)Bertarelli & Cie, a societe en commandite par actions
organized under the laws of Switzerland, which is the holder
of all of the issued and outstanding capital stock of Emfeld
Ltd; and
(iv) Ernesto Bertarelli, an individual, who, as President,
Managing Director and controlling shareholder of Bertarelli
& Cie, controls that entity.
ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
For Feldon Invest SA:
Urbanizacion Obarrio
Swiss Bank Building
53rd Street
Panama City, Panama
For Emfeld Ltd:
One Capital Place
Second Floor
P.O. Box 1787
George Town, Grand Cayman, Cayman Islands
For Ernesto Bertarelli and Bertarelli & Cie:
c/o Abacus Conseil et Expertise Comptable SA
2, Chemin des Mines
CH-1202 Geneva
Switzerland
ITEM 2(C). CITIZENSHIP:
Feldon Invest SA: A stock company organized under the laws of
Panama
Emfeld Ltd: A stock company organized under the laws of the
Cayman Islands
Bertarelli & Cie: A societe en commandite par actions organized
under the laws of Switzerland
CUSIP NO. 75886F 10 7 13G PAGE 7 --------- of ------- 16 PAGES
---
Ernesto Bertarelli: Switzerland
ITEM 2(D). TITLE OF CLASS OF SECURITIES:
Common Stock, par value $0.001 per share
ITEM 2(E). CUSIP NUMBER:
75886F 10 7
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 13D-2(B)
OR (C), CHECK WHETHER THE PERSON FILING IS A:
Not applicable.
ITEM 4. OWNERSHIP.
The ownership percentage set forth below is based on 40,787,624 shares of
common stock outstanding, as reported in the issuer's prospectus dated March 19,
2001.
With respect to Feldon Invest SA:
(a) Amount beneficially owned: 4,000,000
(b) Percent of class: 9.8%
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote: N/A
(ii) Shared power to vote or to direct the vote: 4,000,000
(iii)Sole power to dispose or to direct the disposition of:
N/A
(iv) Shared power to dispose or to direct the disposition
of: 4,000,000
With respect to Emfeld Ltd:
(a) Amount beneficially owned: 4,000,000
(b) Percent of class: 9.8%
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote: N/A
(ii) Shared power to vote or to direct the vote: 4,000,000
(iii)Sole power to dispose or to direct the disposition of:
N/A
(iv) Shared power to dispose or to direct the disposition
of: 4,000,000
CUSIP NO. 75886F 10 7 13G PAGE 8 --------- of ------- 16 PAGES
---
With respect to Bertarelli & Cie:
(a) Amount beneficially owned: 4,000,000
(b) Percent of class: 9.8%
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote: N/A
(ii) Shared power to vote or to direct the vote: 4,000,000
(iii)Sole power to dispose or to direct the disposition of:
N/A
(iv) Shared power to dispose or to direct the disposition
of: 4,000,000
With respect to Ernesto Bertarelli:
(a) Amount beneficially owned: 4,000,000
(b) Percent of class: 9.8%
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote: N/A
(ii) Shared power to vote or to direct the vote: 4,000,000
(iii)Sole power to dispose or to direct the disposition of:
N/A
(iv) Shared power to dispose or to direct the disposition
of: 4,000,000
CUSIP NO. 75886F 10 7 13G PAGE 9 --------- of ------- 16 PAGES
---
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
Not applicable.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
Not applicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL
PERSON.
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Not applicable.
ITEM 10. CERTIFICATIONS.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not held for
the purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
CUSIP NO. 75886F 10 7 13G PAGE 10 -------- of ------- 16 PAGES
---
SIGNATURE
After reasonable inquiry and to the best of our knowledge and belief, we
certify that the information set forth in this statement is true, complete and
correct.
Dated: March 30, 2001
FELDON INVEST SA
/s/ Thomas J. Plotz
----------------------
By: Thomas J. Plotz
Title: Attorney-in-Fact
EMFELD LTD
/s/ Thomas J. Plotz
------------------------
By: Thomas J. Plotz
Title: Attorney-in-Fact
BERTARELLI & CIE
/s/ Thomas J. Plotz
-------------------------
By: Thomas J. Plotz
Title: Attorney-in-Fact
/s/ Ernesto Bertarelli*
-------------------------
Ernesto Bertarelli
* By:
/s/ Thomas J. Plotz
---------------------------------
Thomas J. Plotz, Attorney-in-Fact
CUSIP NO. 75886F 10 7 13G PAGE 11 -------- of ------- 16 PAGES
---
EXHIBITS
1. Power of Attorney of Feldon Invest SA Page 12
2. Power of Attorney of Emfeld Ltd Page 13
3. Power of Attorney of Bertarelli & Cie Page 14
4. Power of Attorney of Ernesto Bertarelli Page 15
5. Joint Filing Agreement Pursuant to Rule 13d-1(k)(1) Page 16
CUSIP NO. 75886F 10 7 13G PAGE 12 -------- of ------- 16 PAGES
---
Exhibit 1
---------
March 23, 2001
POWER OF ATTORNEY
-----------------
The undersigned, Feldon Invest SA, a stock Company organized under the laws
of Panama, by its representatives thereunto duly authorized, hereby constitutes
and appoints Thomas J. Plotz, of Shaw Pittman, Washington, D.C., U.S.A., with
full power of substitution, its true and lawful attorney-in-fact and agent, in
any and all capacities, to sign any and all reports, documents and certificates
to be delivered or filed with respect to the ownership, direct or indirect, of
the undersigned of shares of the capital stock of Regeneron Pharmaceuticals,
Inc., a New York corporation, including, but not limited to, the Schedule 13D or
Schedule 13G, the Form 3, any Form 4, any Form 5 and any amendment to any of the
foregoing, each to be filed with the United States Securities and Exchange
Commission, and to file any such other reports, documents and certificates with
respect thereto with any agencies and instrumentalities and other persons with
which such other reports, documents or certificates are required to be filed or
delivered; and the undersigned hereby grants unto said attorney-in-fact and
agent full power and authority to do and perform each and every act and thing
requisite and necessary to be done in and about the premises, as fully to all
intents and purposes as it might or could do in person, and hereby ratifies and
confirms all that said attorney-in-fact and agent, or other substitutes, may
lawfully do or cause to be done.
Feldon Invest SA
By: /s/ Georges Muller
-------------------------
Name: Georges Muller
Title: Director
By: /s/ Ernesto Pinci
-------------------------
Name: Ernesto Pinci
Title: Director
CUSIP NO. 75886F 10 7 13G PAGE 13 -------- of ------- 16 PAGES
---
Exhibit 2
---------
March 23, 2001
POWER OF ATTORNEY
-----------------
The undersigned, Emfeld Ltd, a stock Company organized under the laws of
the Cayman Islands, by its representatives thereunto duly authorized, hereby
constitutes and appoints Thomas J. Plotz, of Shaw Pittman, Washington, D.C.,
U.S.A., with full power of substitution, its true and lawful attorney-in-fact
and agent, in any and all capacities, to sign any and all reports, documents and
certificates to be delivered or filed with respect to the ownership, direct or
indirect, of the undersigned of shares of the capital stock of Regeneron
Pharmaceuticals, Inc., a New York corporation, including, but not limited to,
the Schedule 13D or Schedule 13G, the Form 3, any Form 4, any Form 5 and any
amendment to any of the foregoing, each to be filed with the United States
Securities and Exchange Commission, and to file any such other reports,
documents and certificates with respect thereto with any agencies and
instrumentalities and other persons with which such other reports, documents or
certificates are required to be filed or delivered; and the undersigned hereby
grants unto said attorney-in-fact and agent full power and authority to do and
perform each and every act and thing requisite and necessary to be done in and
about the premises, as fully to all intents and purposes as it might or could do
in person, and hereby ratifies and confirms all that said attorney-in-fact and
agent, or other substitutes, may lawfully do or cause to be done.
Emfeld Ltd
By: /s/ Georges Muller
-----------------------------
Name: Georges Muller
Title: Director
By: /s/ Ernesto Pinci
-----------------------------
Name: Ernesto Pinci
Title: Director
CUSIP NO. 75886F 10 7 13G PAGE 14 -------- of ------- 16 PAGES
---
Exhibit 3
---------
March 26, 2001
POWER OF ATTORNEY
-----------------
The undersigned, BERTARELLI & CIE, a societe en commandite par actions
organized under the laws of Switzerland, by its representatives thereunto duly
authorized, hereby constitutes and appoints Thomas J. Plotz, of Shaw Pittman,
Washington, D.C., U.S.A., with full power of substitution, its true and lawful
attorney-in-fact and agent, in any and all capacities, to sign any and all
reports, documents and certificates to be delivered or filed with respect to the
ownership, direct or indirect, of the undersigned of shares of the capital stock
of Regeneron Pharmaceuticals, Inc., a New York corporation, including, but not
limited to, the Schedule 13D or Schedule 13G, the Form 3, any Form 4, any Form 5
and any amendment to any of the foregoing, each to be filed with the United
States Securities and Exchange Commission, and to file any such other reports,
documents and certificates with respect thereto with any agencies and
instrumentalities and other persons with which such other reports, documents or
certificates are required to be filed or delivered; and the undersigned hereby
grants unto said attorney-in-fact and agent full power and authority to do and
perform each and every act and thing requisite and necessary to be done in and
about the premises, as fully to all intents and purposes as it might or could do
in person, and hereby ratifies and confirms all that said attorney-in-fact and
agent, or other substitutes, may lawfully do or cause to be done.
BERTARELLI & CIE
By: /s/ Ernesto Bertarelli
---------------------------------
Name: Ernesto Bertarelli
Title: President and Managing
Director
By: /s/ Georges Muller
---------------------------------
Name: Georges Muller
Title: Director and
Vice President
CUSIP NO. 75886F 10 7 13G PAGE 15 -------- of ------- 16 PAGES
---
Exhibit 4
---------
March 26, 2001
POWER OF ATTORNEY
-----------------
The undersigned, ERNESTO BERTARELLI, a citizen and resident of Switzerland,
hereby constitutes and appoints Thomas J. Plotz, of Shaw Pittman, Washington,
D.C., U.S.A., with full power of substitution, his true and lawful
attorney-in-fact and agent, in any and all capacities, to sign any and all
reports, documents and certificates to be delivered or filed with respect to the
ownership, direct or indirect, of the undersigned of shares of the capital stock
of Regeneron Pharmaceuticals, Inc., a New York corporation, including, but not
limited to, the Schedule 13D or Schedule 13G, the Form 3, any Form 4, any Form 5
and any amendment to any of the foregoing, each to be filed with the United
States Securities and Exchange Commission, and to file any such other reports,
documents and certificates with respect thereto with any agencies and
instrumentalities and other persons with which such other reports, documents or
certificates are required to be filed or delivered; and the undersigned hereby
grants unto said attorney-in-fact and agent full power and authority to do and
perform each and every act and thing requisite and necessary to be done in and
about the premises, as fully to all intents and purposes as he might or could do
in person, and hereby ratifies and confirms all that said attorney-in-fact and
agent, or other substitutes, may lawfully do or cause to be done.
By: /s/ Ernesto Bertarelli
---------------------------------
Ernesto Bertarelli
CUSIP NO. 75886F 10 7 13G PAGE 16 -------- of ------- 16 PAGES
---
Exhibit 5
---------
Joint Filing Agreement Pursuant to Rule 13d-1(k)(1)
The undersigned hereby agree that this document shall be filed on behalf of each
of them.
FELDON INVEST SA
By: /s/ Thomas J. Plotz
------------------------------
Name: Thomas J. Plotz
Title: Attorney-in-Fact
EMFELD LTD
By: /s/ Thomas J. Plotz
------------------------------
Name: Thomas J. Plotz
Title: Attorney-in-Fact
BERTARELLI & CIE
By: /s/ Thomas J. Plotz
-----------------------------
Name: Thomas J. Plotz
Title: Attorney-in-Fact
By: /s/ Ernesto Bertarelli*
------------------------------
*By: /s/ Thomas J. Plotz Ernesto Bertarelli
-----------------------------
Thomas J. Plotz, Attorney-in-Fact
Dated: March 30, 2001